ArticleAlzheimer's research & therapy2026
EEG biomarkers can predict early-stage Alzheimer's disease and correlate with intracerebral pathology: a multimodal machine learning study.
Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engram cell vulnerability in neurodegeneration: from mechanistic insights to therapeutic horizons.Frontiers in aging neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundEarly recognition of Alzheimer's disease (AD) is crucial for timely intervention and delaying disease progression. Electroencephalogram (EEG) technology provides a direct reflection of the brain's dynamic activity. However, the relationship between potential EEG features and cognitive function in early-stage AD patients, as well as cerebrospinal fluid (CSF) pathological biomarkers, remains unclear.
methodsThis study included 101 patients with mild cognitive impairment (MCI) and mild AD, alongside 69 healthy controls (HC) matched for gender, age, and educational attainment. Extracting EEG power spectral density (PSD) and microstates analysis features as training features for machine learning (ML), we employed five ML algorithms-Support Vector Machines (SVM), Logistic Regression (LR), Random Forests (RF), XGBoost, and LightGBM-for training and testing. Model performance was assessed using the area under the receiver operating characteristic curve (AUC). SHapley Additive exPlanations (SHAP) plots were employed to elucidate variable importance within the model, and sequential forward selection (SFS) was utilised to identify potential features. Correlation analysis and mediation analysis were conducted to investigate the relationships between EEG features, CSF pathological biomarkers, and cognitive function.
resultsThe LR model demonstrated the highest average predictive performance in the training set (mean AUC = 0.859 ± 0.059). The model incorporating PSD and microstates features demonstrated optimal predictive performance in the test set (AUC = 0.949, 95% CI: 0.877-1.000), outperforming any single-feature model. Based on SHAP and SFS analyses, six potential EEG indicators were identified: central region delta frequency band, central region theta frequency band, temporal region beta frequency band, microstate mean duration, microstate C duration, and the transition probability from microstate C to A. Mediation analysis revealed a significant negative correlation between central region theta frequency band and CSF Aβ₁₋₄₂ levels (r = - 0.31, p = 0.015), and the central region theta frequency band mediated the relationship between Aβ₁₋₄₂ levels and Mini-Mental State Examination (MMSE) scores (indirect effect = 0.0007, 95% CI: 0.0001-0.0013).
conclusionThe combined application of EEG and ML enables efficient classification diagnosis of early-stage AD, and EEG is correlated with intracerebral pathological biomarkers and cognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.